Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Conference Call August 19, 2025 5:00 PM ET
Company Participants
Bradford K. Amman – CFO, Treasurer & Secretary
R. Kirk Huntsman – Co-Founder, Chairman of the Board & CEO
Conference Call Participants
Robert Sassoon – Water Tower Research LLC
Scott Robert Henry – Alliance Global Partners, Research Division
Operator
Good day, everyone, and welcome to the Vivos Second Quarter 2025 Conference Call. [Operator Instructions] This conference call is being recorded, and a replay of today’s call will be available on the Investor Relations section of Vivos’ website and will remain posted there for the next 30 days. I will now hand the call over to Mr. Brad Amman, Chief Financial Officer, for introductions and the reading of the safe harbor statement. Please go ahead.
Bradford K. Amman
Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com.
With me on the call today is Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer. Today, we’ll review the financial results for the second quarter 2025 as well as more recent developments and Vivos’ plans for the rest of the — 2025 and beyond. Following these formal remarks, we will be happy to take questions.
I would like to remind everyone that today’s call will contain forward-looking statements from our management made within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities and Exchange Act of 1934 as amended concerning future events. Words such as aim, may, could, should, projects, expects, intends, plans, believes, anticipates, hopes, estimates, goal and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve significant known and unknown risks that are based upon a number of assumptions and estimates, which
#Vivos #Therapeutics #VVOS #Earnings #Call #Transcript